Department of Gastroenterology, University of California, San Francisco, San Francisco, CA.
Department of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York City, NY.
Liver Transpl. 2019 May;25(5):706-711. doi: 10.1002/lt.25448. Epub 2019 Mar 29.
Alcohol-associated liver disease (ALD) can be coded in United Network for Organ Sharing (UNOS) as either alcoholic cirrhosis or alcoholic hepatitis (AH), without having specific criteria to assign either diagnosis. In this multicenter American Consortium of Early Liver Transplantation for Alcoholic Hepatitis (ACCELERATE-AH) study, we sought to assess the concordance of the clinician diagnosis of AH at liver transplantation (LT) listing versus UNOS data entry of AH as listing diagnosis. In a prior study, consecutive early LT recipients transplanted for AH between 2012 and 2017 were identified by chart review at 10 ACCELERATE-AH sites. In this current study, these same LT recipients were identified in the UNOS database. The primary UNOS diagnostic code was evaluated for concordance with the chart-review assignment of AH. In cases where the primary listing diagnosis in UNOS was not AH, we determined the reason for alternate classification. Among 124 ACCELERATE-AH LT recipients with a chart-review diagnosis of AH, only 43/124 (35%) had AH as listing diagnosis in UNOS; 80 (64%) were listed as alcoholic cirrhosis, and 1 (1%) as fulminant hepatic necrosis. Of the 81 patients missing AH as a UNOS listing diagnosis code, the reasons for alternate classification were 44 (54%) due to a lack of awareness of a separate diagnosis code for AH; 13 (16%) due to concomitant clinical diagnosis of AH and alcoholic cirrhosis in the chart; 12 (15%) due to clinical uncertainty regarding the diagnosis of AH versus acute decompensated alcoholic cirrhosis; and 12 (15%) due to a data entry error. In conclusion, in a large cohort of LT recipients with AH, only 35% were documented as such in UNOS. Increased education and awareness for those performing UNOS data entry, the establishment of specific criteria to define AH in the UNOS database, and the ability to document dates of alcohol use would allow future research on ALD to be more informative.
酒精相关性肝病(ALD)可以在美国器官共享联合网络(UNOS)中被编码为酒精性肝硬化或酒精性肝炎(AH),而无需特定标准来分配任何诊断。在这项多中心美国酒精性肝炎早期肝移植联合研究(ACCELERATE-AH)中,我们试图评估肝移植(LT)列表上的 AH 临床诊断与 UNOS 数据录入中 AH 作为列表诊断的一致性。在之前的一项研究中,通过在 10 个 ACCELERATE-AH 地点进行图表审查,确定了 2012 年至 2017 年间连续接受早期 LT 治疗的酒精性肝炎患者。在本研究中,这些相同的 LT 受者在 UNOS 数据库中被识别。评估了主要 UNOS 诊断代码与图表审查中 AH 分配的一致性。在 UNOS 中主要列表诊断不是 AH 的情况下,我们确定了替代分类的原因。在 124 名接受 ACCELERATE-AH LT 治疗且经图表审查诊断为 AH 的患者中,仅有 43/124(35%)在 UNOS 中被列为 AH 列表诊断;80 例(64%)被列为酒精性肝硬化,1 例(1%)为暴发性肝坏死。在 81 名未将 AH 列为 UNOS 列表诊断代码的患者中,替代分类的原因分别为 44 例(54%)是因为缺乏对 AH 单独诊断代码的认识;13 例(16%)是因为图表中同时存在 AH 和酒精性肝硬化的临床诊断;12 例(15%)是因为 AH 与急性失代偿性酒精性肝硬化的诊断存在临床不确定性;12 例(15%)是因为数据录入错误。总之,在接受 LT 治疗的大量 AH 患者中,只有 35%在 UNOS 中被记录为 AH。对进行 UNOS 数据录入的人员进行更多的教育和认识,在 UNOS 数据库中建立明确界定 AH 的标准,以及记录饮酒日期的能力,将使未来关于 ALD 的研究更具信息量。